News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Bound for Everest

Fresh off of summiting Aconcagua, the highest peak in South America, Alan Arnette is at it again. This spring, he will attempt to summit Everest—the highest peak on Earth at 29,035 feet. Everest is the third mountain in his 7 Summits Climb for Alzheimer’s: Memories are Everything campaign—his yearlong mission to scale the highest peak on each of the seven continents to raise money for the fight against Alzheimer’s.

Relationship Between the APOE Genotype and Alzheimer's Disease

A meeting of the minds

One of the most important, outstanding genetic questions about Alzheimer’s disease is the relationship between the APOE genotype and the risk associated with the disease. To better understand this topic and speed progress, Cure Alzheimer’s Fund (CAF) sponsored a meeting in February 2010 to explore this issue. The body of biological knowledge regarding how and why APOE likely is linked with AD was discussed in detail by members of the CAF Research Consortium and Cheryl Wellington, Ph.D., University of British Columbia; Michael Brown, M.D., University of Texas; Karl Weisgraber, Ph.D., Gladstone Institute; Alan Tall, Ph.D., Columbia University; and Joachim Herz, M.D., University of Texas, whose record of research includes valuable insights into this relationship. The meeting led to some important, newly funded research, including a project by David Holtzman, M.D., in his lab at Washington University in St. Louis.

Dispatches from Alan Arnette at Everest base camp on his 7 Summits Climb for Alzheimer's

Alan Arnette, a long time Alzheimer’s Advocate and friend of The Cure Alzheimer’s Fund, is at base camp and is finalizing his training and preparing to summit Mt. Everest. This will be the third climb of his 7 Summits Climb for Alzheimer’s: Memories are Everything campaign where he is raising awareness and $1M for Alzheimer’s research. He took a few minutes to share his thoughts on Alzheimer’s research. Climb on Alan.

 


Dispatches from Everst Base Camp

Alzheimer’s Genes in the News: What does it all mean?

Setting the stage

The 10th Annual International Conference on Alzheimer’s Disease/Parkinson’s Disease (AD/PD) was held this March in Barcelona with thousands of researchers from 68 countries attending. Chief among the topics of interest was determining risk for the disease from genetics. The useful source for all things Alzheimer’s, The Alzheimer’s Research Forum (www.alzforum.org), provided extensive coverage on the conference.

Welcome Julie Ann Winton to the Cure Alzheimer’s Fund team!

Julie is joining Cure Alzheimer’s Fund as Development and Communications Associate to help provide content and direction to our communications program, support our fundraising efforts, help manage and expand our outreach programs and generally provide administrative support for Cure Alzheimer’s Fund and related researchers.

Deepak Chopra interviews CAF's Dr. Rudy Tanzi on this innovative Alzheimer's research

In this video Deepak Chopra talks to Dr. Rudy Tanzi about his groundbreaking research project, the Alzheimer's Genome Project, how gaining a better understanding of Alzheimer's disease leads to better treatments and a possible cure, and the important support of Cure Alzheimer's Fund in his research efforts.

Running to Support Research

Running4Answers

Save the date – April 2, 2011! Join Running4Answers for the second annual 4-mile race and 2-mile fun run/fitness walk. The race will take place on the beautiful tree-lined, rolling hill streets of historic Roseland and Essex Fells, NJ. The race course is USATF-NJ sanctioned and certified and it is also part of the GRAND PRIX series. All proceeds go to support Cure Alzheimer’s Fund and research for a cure.

Alzheimer’s Genome Project Helps Progress for a Cure

Dr. Rudy Tanzi describes the role of Cure Alzheimer’s Fund and the Alzheimer’s Genome Project(link to AGP) in recent progress in Alzheimer’s disease research in a posting on NaplesNews.com. He explains:

Prior to the Alzheimer’s Genome Project, we had discovered only four genes implicated in Alzheimer’s. And while these genes accounted for 30 percent of the inheritance of Alzheimer’s, we still had 70 percent of the genes left to discover.

CAF Applauds Recent Bipartisan Efforts by the Federal Government to Address Alzheimer’s Disease

Cure Alzheimer’s Fund applauds recent administration and congressional bipartisan action to help in the fight against Alzheimer’s.  Two recent events deserve acknowledgement and recognition.

National Family Caregivers Association Joins The 7 Summits Climb

Cure Alzheimer’s Fund together with Janssen Alzheimer Immunotherapy and Pfizer is pleased to announce the addition of the National Family Caregivers Association (NFCA) to The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign.  NFCA joins just as alpine mountaineer and Alzheimer’s disease advocate Alan Arnette successfully summitted Aconcagua in Argentina, his second climb of the 7 Summits.  Congratulations Alan!